| P2093 | author name string | A Carlsson | |
| | C Wallon | |
| | J D Söderholm | |
| | J Gerritsen | |
| | L M A Akkermans | |
| | M Persborn | |
| P2860 | cites work | Increased bacterial permeation in long-lasting ileoanal pouches. | Q51143689 |
| | Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. | Q51654969 |
| | An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota. | Q52849262 |
| | Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. | Q52940886 |
| | Comprehensive analysis of the bacterial content of stool from patients with chronic pouchitis, normal pouches, or familial adenomatous polyposis pouches. | Q54337406 |
| | Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. | Q54633909 |
| | Acute pouchitis and deficiencies of fuel | Q56441829 |
| | VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 |
| | Multivariate Analysis of Ecological Data using CANOCO | Q104207190 |
| | Intestinal microbiota in human health and disease: the impact of probiotics | Q24628739 |
| | Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine | Q24685766 |
| | The role of microbiota and probiotics in stress-induced gastro-intestinal damage. | Q30369819 |
| | Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis | Q30978199 |
| | Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA). | Q33212468 |
| | Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults | Q33464636 |
| | Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial | Q34300645 |
| | Pouchitis: result of microbial imbalance? | Q34378691 |
| | Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial | Q34510060 |
| | Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. | Q34547390 |
| | Review article: treatment of mild to moderate ulcerative colitis and pouchitis | Q34669202 |
| | Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis | Q35596222 |
| | The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing | Q35799373 |
| | Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice | Q36273531 |
| | Review article: restorative proctocolectomy, indications, management of complications and follow-up--a guide for gastroenterologists | Q37081799 |
| | Pathogenesis of and unifying hypothesis for idiopathic pouchitis | Q37405919 |
| | Probiotic bacteria and intestinal epithelial barrier function | Q37714234 |
| | Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. | Q38427339 |
| | Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis | Q39600984 |
| | A shift from colon- to ileum-predominant bacteria in ileal-pouch feces following total proctocolectomy | Q39624261 |
| | Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro. | Q40128148 |
| | Role of oxygen free radicals in the etiology of pouchitis | Q40734341 |
| | Probiotic bacteria enhance murine and human intestinal epithelial barrier function | Q40783633 |
| | Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications | Q41667728 |
| | Integrity and metabolism of human ileal mucosa in vitro in the Ussing chamber | Q42451878 |
| | Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats | Q43005151 |
| | Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis | Q43328233 |
| | Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis | Q43353936 |
| | Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial | Q43363077 |
| | Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. | Q43746137 |
| | A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis | Q43807182 |
| | Variable response to probiotics in two models of experimental colitis in rats. | Q44231461 |
| | The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis | Q44504044 |
| | Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis | Q45019303 |
| | Association between fecal hydrogen sulfide production and pouchitis | Q45300584 |
| | Permanently increased mucosal permeability in patients with backwash ileitis after ileoanal pouch for ulcerative colitis | Q46526875 |
| | Endoscopic biopsies in Ussing chambers evaluated for studies of macromolecular permeability in the human colon | Q46612637 |
| | Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. | Q51044577 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| | probiotics | Q1816730 |
| | pouchitis | Q3392956 |
| P304 | page(s) | 772-783 | |
| P577 | publication date | 2013-08-19 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis | |
| P478 | volume | 38 | |